It would be interesting to know, because on the adverse reactions—as my colleague Ms. Fry has said—this committee studied that quite seriously. We were somewhat shocked to learn how few of those are coming in from physicians, how few of those are coming in from citizens, and how heavily we're depending on other countries and the companies themselves who produce the products. So we are not sure that is a dispassionate source of this information. It has to be pretty serious before the company is going to squeal on itself.
On February 7th, 2007. See this statement in context.